CSF GABA and neuropeptides in pathological gamblers and normal controls. 1989

A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
Hillside Hospital, Division of Long Island Jewish Medical Center, Glen Oaks, NY 11004.

We previously reported that pathological gamblers may have increased central noradrenergic activity. Neurons releasing gamma-aminobutyric acid (GABA) are known to be a part of an inhibitory system regulating the activity of central noradrenergic neurons. Therefore, we examined cerebrospinal fluid (CSF) levels of GABA in pathological gamblers and normal controls. There was no significant difference between the groups. Also, depressed and nondepressed gamblers did not differ significantly in their CSF levels of GABA. Among controls, however, there was a significant negative correlation between CSF levels of GABA and the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) and a significant positive correlation between CSF levels of GABA and corticotropin releasing hormone (CRH). Also, CSF levels of CRH showed a significant positive correlation with CSF levels of adrenocorticotropic hormone in both pathological gamblers and controls.

UI MeSH Term Description Entries
D008297 Male Males
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D005680 gamma-Aminobutyric Acid The most common inhibitory neurotransmitter in the central nervous system. 4-Aminobutyric Acid,GABA,4-Aminobutanoic Acid,Aminalon,Aminalone,Gammalon,Lithium GABA,gamma-Aminobutyric Acid, Calcium Salt (2:1),gamma-Aminobutyric Acid, Hydrochloride,gamma-Aminobutyric Acid, Monolithium Salt,gamma-Aminobutyric Acid, Monosodium Salt,gamma-Aminobutyric Acid, Zinc Salt (2:1),4 Aminobutanoic Acid,4 Aminobutyric Acid,Acid, Hydrochloride gamma-Aminobutyric,GABA, Lithium,Hydrochloride gamma-Aminobutyric Acid,gamma Aminobutyric Acid,gamma Aminobutyric Acid, Hydrochloride,gamma Aminobutyric Acid, Monolithium Salt,gamma Aminobutyric Acid, Monosodium Salt
D005715 Gambling An activity distinguished primarily by an element of risk in trying to obtain a desired goal, e.g., playing a game of chance for money. Pathological Gambling,Gambling, Pathologic,Gambling, Pathological,Gamblings,Gamblings, Pathological,Pathological Gamblings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012309 Risk-Taking Undertaking a task involving a challenge for achievement or a desirable goal in which there is a lack of certainty or a fear of failure. It may also include the exhibiting of certain behaviors whose outcomes may present a risk to the individual or to those associated with him or her. Risk Behavior,Behavior, Risk,Behaviors, Risk,Risk Behaviors,Risk Taking

Related Publications

A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
April 1990, Biological psychiatry,
A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
August 2006, Journal of psychiatric research,
A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
January 2008, Journal of addictive diseases,
A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
January 2007, Journal of neural transmission (Vienna, Austria : 1996),
A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
March 2012, Journal of gambling studies,
A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
February 1987, The British journal of psychiatry : the journal of mental science,
A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
January 1985, Progress in neuro-psychopharmacology & biological psychiatry,
A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
April 2005, Brain research. Cognitive brain research,
A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
January 2007, Neuropsychobiology,
A Roy, and J DeJong, and T Ferraro, and B Adinoff, and P Gold, and D Rubinow, and M Linnoila
January 1982, Advances in neurology,
Copied contents to your clipboard!